Q1 2015 Holdings
Filed 2015-05-15 | 71 holdings | $29.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ardelyx Inc(ARDX) | COM | 039697107 | $13.3M | 1,013,785 | 44.6% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $6.7M | 219,130 | 22.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.1M | 680,000 | 20.6% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $1.1M | 100,300 | 3.7% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.1M | 61,500 | 3.6% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $865.0K | 25,000 | 2.9% |
| Receptos Inc | COM | 756207106 | $64.4K | 390,312 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $42.7K | 700,000 | 0.1% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $39.5K | 167,300 | 0.1% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $30.0K | 716,500 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $29.6K | 459,000 | 0.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $28.5K | 718,900 | 0.1% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $21.8K | 574,500 | 0.1% |
| Sorrento Therapeutics Inc(SRNE) | COM NEW | 83587F202 | $19.1K | 1,652,912 | 0.1% |
| Dyax Corp | COM | 26746E103 | $19.1K | 1,138,900 | 0.1% |
| Quotient LTD | SHS | G73268107 | $19.0K | 1,119,100 | 0.1% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $18.5K | 1,270,000 | 0.1% |
| Ovascience Inc | COM | 69014Q101 | $16.1K | 462,720 | 0.1% |
| Regulus Therapeutics Inc | COM | 75915K101 | $15.2K | 896,522 | 0.1% |
| Advaxis Inc | COM NEW | 007624208 | $14.1K | 975,375 | 0.0% |
| Tesaro Inc | COM | 881569107 | $11.0K | 191,250 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $10.5K | 826,000 | 0.0% |
| Novavax Inc | COM | 670002104 | $10.2K | 1,238,300 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $9.5K | 153,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $9.2K | 300,987 | 0.0% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $9.2K | 317,475 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $8.7K | 229,500 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $8.6K | 388,500 | 0.0% |
| Epirus Biopharmaceuticals in | COM | 29428P107 | $8.0K | 896,600 | 0.0% |
| Pfenex Inc | COM | 717071104 | $7.6K | 474,900 | 0.0% |
| China Biologic Prods Inc | COM | 16938C106 | $7.3K | 76,500 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $7.2K | 1,409,000 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $7.2K | 255,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $6.9K | 442,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $6.5K | 170,000 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $6.3K | 102,000 | 0.0% |
| Curis Inc | COM | 231269101 | $6.3K | 2,632,000 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $6.3K | 850,000 | 0.0% |
| Recro Pharma Inc | COM | 75629F109 | $5.9K | 655,907 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $5.8K | 1,081,867 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $5.8K | 100,000 | 0.0% |
| Minerva Neurosciences Inc(NERVGBP) | COM | 603380106 | $5.7K | 1,145,043 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $5.1K | 424,815 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $5.0K | 266,250 | 0.0% |
| Lipocine Inc New | COM | 53630X104 | $4.6K | 666,666 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $4.4K | 397,500 | 0.0% |
| Synageva Biopharma Corp | COM | 87159A103 | $4.1K | 42,500 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $4.1K | 170,000 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $3.8K | 458,955 | 0.0% |
| Genvec Inc | COM NEW | 37246C307 | $3.7K | 1,262,835 | 0.0% |